Fundraising FoxAccess Industries — 2018 Investments
3 investments dated 2018 · listed companies and verified rows first · show all
Cadent Therapeutics was a Cambridge, Massachusetts-based neuroscience company developing clinical-stage therapies for neuropsychiatric disorders including schizophrenia, movement disorders, and treatment-resistant depression.
BiotechDigital HealthHealthtechMedical DevicesCambridge, US
Co-investorsQiming Venture Partners USASlater Technology FundAtlas VentureClal Biotechnology IndustriesCowen Healthcare InvestmentsNovartis Institute for Biomedical Research+1 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.